Jazz and Werewolf announce global license and collaboration agreement to develop WTX-613 April 8, 2022 No Comments
T cell-intrinsic AR activity drives IFN-gamma suppression and immunotherapy resistance April 7, 2022 No Comments
Harbour BioMed and AstraZeneca enter global outlicense agreement for HBM-7022 April 7, 2022 No Comments
Atreca announces agreement with Zymeworks and selection of new clinical candidate April 6, 2022 No Comments
Guangzhou Maxinovel Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors April 5, 2022 No Comments
RSS